Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07231471 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma for Musculoskeletal Conditions
A NA study of Tendinopathy and Osteoarthritis (OA) of the Knee, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 10,000
- Enrollment target
- 1
- Study location
NCT07231471 is a NA study of Tendinopathy and Osteoarthritis (OA) of the Knee that is actively recruiting participants, run by University of Utah. The registered enrollment target is 10,000 participants, above the 67-participant average among 10 other Tendinopathy trials with a reported enrollment target (14825% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07231471, a NA study of Tendinopathy and Osteoarthritis (OA) of the Knee, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Conditions Studied
Interventions
- BIOLOGICAL Platelet Rich Plasma Injection
- DEVICE Platelet Rich Plasma Preparation
Study Locations (1)
Utah
- University of Utah Orthoaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2025-12-29 |
| Est. Completion | 2035-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07231471
The ClinicalTrials.gov registry entry for NCT07231471 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 67-participant average among 10 other Tendinopathy trials with a reported enrollment target (14825% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Tendinopathy appearing as the primary indexed condition, and to 2 interventions - of which Platelet Rich Plasma Injection is the first listed.
NCT07231471 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT07231471 about?
NCT07231471 is a clinical study titled "Platelet Rich Plasma for Musculoskeletal Conditions". The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will de...
What is the current status of trial NCT07231471?
This trial is currently recruiting. It is a NA study. The enrollment target is 10,000 participants. The study started on 2025-12-29. Estimated completion is 2035-01-01.
What conditions does trial NCT07231471 study?
This clinical trial studies the following conditions: Tendinopathy, Osteoarthritis (OA) of the Knee, Osteoarthritis Ankle, Osteoarthritis (OA) of the Hip, Plantar Fasciitis of Both Feet.
What interventions are being tested in trial NCT07231471?
The interventions under investigation include: Platelet Rich Plasma Injection (BIOLOGICAL), Platelet Rich Plasma Preparation (DEVICE).
Who is sponsoring clinical trial NCT07231471?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07231471 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tendinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
RECRUITING · NA
-
Long Duration Therapeutic Ultrasound for Tendon Healing
COMPLETED · NA
-
PRP vs PRP Plus IGF for Patellar Tendinosis
COMPLETED · NA
-
Achilles Tendon Repair With Bioinductive Implant
COMPLETED · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
Assessing the Tendons With Shear Wave Elastography
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.